I am a nuclear medicine physician whose clinical interests focus on the use of positron emission tomography (PET) for diagnostic and molecular imaging. I also have special expertise in the care and management of patients who receive radiotargeted therapy, particularly for thyroid cancer.
I am Head of the Nuclear Medicine Research Laboratory. I am also a member of the Executive Council for the Molecular Pharmacology and Chemistry Program of the Sloan Kettering Institute. My research interests involve PET and targeted therapy in oncology. I have had a long-term interest in radiopharmaceuticals for oncologic applications in nuclear medicine and have been working in various aspects of PET since 1979.